Guidance for market authorization requirements for COVID-19 drugs: Overview (English, HTML)

Guidance for market authorization requirements for COVID-19 drugs: Overview: English HTML file. From Health Canada, updated Jul 2022. View metadata, licence and the direct download on CanQuery.

Format

HTML

Access

Original download only

Publisher-reported update

2022-07-28

This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent changes to the regulatory process for new COVID-19 drugs.

Access original file